It’s been a tough few weeks for the consumer health company Kenvue, after President Trump publicly spread unproven claims about Tylenol, one of its core subsidiary brands. Today, though, it seems like there might finally be some good news for Kenvue.

This morning, Kimberly-Clark, the personal care corporation behind brands like Kleenex, Huggies, and Cottonelle, announced that it’s struck an agreement to acquire Kenvue (which, alongside Tylenol, also owns brands like Band-Aid, Zyrtec, and Listerine). The deal, which is expected to close in the second half of 2026, will proceed through a cash and stock transaction that’s set to value Kenvue at around $48.7 billion.

Kenvue stock was up as much as 19% in premarket trading. As of this writing, Kenvue stock is........

© Fast Company